| 尿激酶型纤溶酶原激活剂及其受体与胃癌关系的研究进展 |
| |
| 引用本文： | 张科,卜平.尿激酶型纤溶酶原激活剂及其受体与胃癌关系的研究进展[J].国际消化病杂志,2008,28(4). |
| |
| 作者姓名： | 张科 卜平 |
| |
| 作者单位： | 225001,扬州大学医学院中西医结合实验室,四楼 |
| |
| 摘 要： | 尿激酶型纤溶酶原激活剂(uPA)及其受体(uPAR)是纤溶系统的重要组成部分,主要通过激活纤溶酶降解细胞外基质,促进肿瘤的浸润与转移。此文就它们与胃癌之间的关系及在临床中的应用作一综述,旨在为胃癌的诊断和治疗提供新方法、开辟新途径。
|
| 关 键 词： | 尿激酶型纤溶酶原激活剂(uPA) 尿激酶型纤溶酶原激活剂受体(uPAR) 胃癌 相关性 |
Research progression of relationship between uPA and uPAR and stomach carcinoma |
| |
| ZHANG Ke,BO Ping.Research progression of relationship between uPA and uPAR and stomach carcinoma[J].International Journal of Digestive Disease,2008,28(4). |
| |
| Authors: | ZHANG Ke BO Ping |
| |
| Abstract: | uPA and uPAR are important ingredients of fibrolysis system,which can degrade extracellular matrix and promote the infiltration and metastasis of tumors mainly through activing fibrinolysin.This review discusses the relationship between uPA and uPAR and stomach carcinoma and the clinical application,in order to provide new approach and develop new way for the diagnosis and therapy of stomach carcinoma. |
| |
| Keywords: | Urokinase-type plasminogen activator uPA receptor Stomach carcinoma Correlation |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
